Biomanufacturing Capacity: The Bottleneck Moves Downstream
Presented at: ISPE Annual Meeting Orlando, FL, Nov 7-10, 2010
The industry is struggling to rebalance upstream and downstream processing. Why and how? Implications on world capacity? Topics covered include:
- What is the status of capacity distribution and utilization within the biopharmaceutical industry?
- The industry is struggling to rebalance upstream and downstream processing. Why and how? Implication on world capacity?
- Advances in single-use processing steps are shifting the way that the industry thinks about capital investment in manufacturing facilities. Is this the technology of the future? What are the issues?